Skip to main content

Canada Opening supervised injection sites in Ontario makes financial sense: study

Unlike in Vancouver’s Downtown Eastside, Dr. Ahmed Bayoumi said multiple facilities would be more appropriate in Ontario, where populations of drug users are more spread out.

iStockphoto/iStockphoto

Opening five supervised injection sites in Ontario makes financial sense, says a medical researcher who based his study on a Vancouver clinic where drug users shoot up under supervision.

Dr. Ahmed Bayoumi of St. Michael's Hospital in Toronto said establishing facilities such as Insite in that city and in Ottawa would save money and reduce the incidence of diseases such as HIV and hepatitis C.

"Three facilities for Toronto and two for Ottawa represent a good investment compared to other things that we ordinarily invest in in health care," he said in an interview Monday.

Story continues below advertisement

Insite is North America's only supervised injection site, where addicts shoot up their own drugs under the watchful eyes of a nurse in order to prevent overdoses.

The site provided a baseline for estimating the approximate cost of operating a supervised injection site as well its effectiveness at improving users' health, Dr. Bayoumi said.

Victoria and other cities across Canada have considered establishing similar facilities.

Montreal announced its intention to open a supervised injection site after a 2011 Supreme Court of Canada decision ruled against the former Conservative government's attempts to shut down Insite for violating federal drug laws.

Unlike in Vancouver's Downtown Eastside, Dr. Bayoumi said multiple facilities would be more appropriate in Ontario, where populations of drug users are more spread out.

He said the study's economic estimates are conservative because they're based on Insite being a freestanding clinic, compared with an approach that would incorporate supervised injection facilities into existing health centres.

While the study focused on needs in Toronto and Ottawa, Dr. Bayoumi said other Ontario cities could also benefit from such facilities.

"The next step is mostly a political decision rather than a research decision, as in, 'Is there an interest and a will to actually establish some facilities?'"

Ontario's Health Minister said a national strategy to deal with intravenous drug users, rather than a piecemeal approach, would be most beneficial.

"I think that more than anything, this is an opportunity to bring together all jurisdictions and look at this in a uniform way," Eric Hoskins said.

"We, up until recently, had a federal government that made it clear they didn't support such sites. We now have a government that understands the science and is willing and prepared and wants to make decisions based on evidence."

The minister said any request for a supervised injection site would have to come from municipal governments.

Insite opened in 2003 as part of a harm-reduction plan to tackle an epidemic of HIV/AIDS and drug overdose deaths in the Downtown Eastside.

Story continues below advertisement

The facility provides clean needles to addicts to stop the spread of infectious diseases before they inject drugs at one of 12 booths.

Studies in major medical journals have hailed the success of Insite, suggesting it has helped reduce overdose deaths, infectious diseases and crime in the 10-block area that draws addicts.

The former federal government was criticized for wanting Insite to be shut down over concerns it promotes drug use, but lost a series of legal battles that kept the clinic open.

Report an error
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Discussion loading ...

Cannabis pro newsletter